Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG1ZN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,709
Award facts
- Contract value 100% obligated
- $15,709.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Opdivo 240 mg/24 mL vials valued at $15,709.47 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Opdivo is an oncology therapeutic used in cancer treatment, reflecting the Defense Logistics Agency's critical role in supplying specialized pharmaceutical products to support Department of Defense and military healthcare systems. AmerisourceBergen's substantial prime IDC with DLA demonstrates the company's established capability to fulfill federal medical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines. The company serves defense healthcare customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting arrangement, which positions it as a key vendor within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FG1ZN?
SPE2DR26FG1ZN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FG1ZN worth?
The government has obligated $15,709 on SPE2DR26FG1ZN.
Is contract SPE2DR26FG1ZN an order under another contract?
Yes. SPE2DR26FG1ZN is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1ZN competed?
The extent of competition for SPE2DR26FG1ZN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award